Skip to content
Back to Investors
N

Nomura

Venture Capital

Portfolio

2

companies

By category

  • HealthTech£92.4M
  • FinTech£77.7M

By location

  • London£170M

Portfolio companies

FI

Fnality International

Fnality International develops blockchain payments technology for wholesale financial markets.

Huma Therapeutics

Huma Therapeutics

Huma Therapeutics builds digital health platforms for care and research.


Recent investments

Series B
£77.7M

The Series B round will help fund the deployment of the company's tokenised cash innovation and global liquidity management ecosystem.

"Our Series B funding round represents the financial sector’s desire for a central bank money backed blockchain-based settlement solution that bridges the gap between traditional finance (TradFi) and decentralised finance (DeFi) in wholesale markets. Each Fnality Payment System utilises DLT to provide a 24/7 payment rail with the ability to reduce settlement cycles to real-time, while significantly improving intraday liquidity management and marking significant innovation in the speed, functionality, and resilience of wholesale payments."
— Rhomaios Ram
Series C
$130M

The Series C financing was led by Leaps by Bayer and Hitachi Ventures to support international expansion and platform development.

"This is a pivotal moment in Huma’s development. We have exceptional partners and strategic investors who will support us in our mission to help people worldwide live longer and fuller lives. We’re already demonstrating how ‘hospital at home’ can transform healthcare, and how decentralized clinical trials can advance research in ways that weren’t imaginable even one year ago. Now we want to accelerate the pace of change and continue to innovate for better care and research worldwide."
— Dan Vahdat